Thermo Fisher Scientific Inc. (NYSE: TMO) open the trading on Wednesday, with a bit cautious approach as it glided -1.69% to $576.49, before settling in for the price of $586.38 at the close. Taking a more long-term approach, TMO posted a 52-week range of $415.60-$627.88.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 12.53% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 16.37%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 0.70%. This publicly-traded company’s shares outstanding now amounts to $386.65 million, simultaneously with a float of $381.39 million. The organization now has a market capitalization sitting at $220.22 billion. At the time of writing, stock’s 50-day Moving Average stood at $606.81, while the 200-day Moving Average is $578.44.
Thermo Fisher Scientific Inc. (TMO) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Diagnostics & Research industry. Thermo Fisher Scientific Inc.’s current insider ownership accounts for 0.16%, in contrast to 90.78% institutional ownership. According to the most recent insider trade that took place on Sep 03 ’24, this organization’s Chairman & CEO sold 10,000 shares at the rate of 608.74, making the entire transaction reach 6,087,445 in total value, affecting insider ownership by 121,192. Preceding that transaction, on Sep 04 ’24, Company’s Chairman & CEO sold 10,000 for 608.15, making the whole transaction’s value amount to 6,081,529. This particular insider is now the holder of 121,192 in total.
Thermo Fisher Scientific Inc. (TMO) Earnings and Revenue Records
Thermo Fisher Scientific Inc.’s EPS increase for this current 12-month fiscal period is 0.70% and is forecasted to reach 23.68 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 7.60% through the next 5 years, which can be compared against the 16.37% growth it accomplished over the previous five years trading on the market.
Thermo Fisher Scientific Inc. (NYSE: TMO) Trading Performance Indicators
Let’s observe the current performance indicators for Thermo Fisher Scientific Inc. (TMO). It’s Quick Ratio in the last reported quarter now stands at 1.26. The Stock has managed to achieve an average true range (ATR) of 11.44. Alongside those numbers, its PE Ratio stands at $36.14, and its Beta score is 0.78. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.20. Similarly, its price to free cash flow for trailing twelve months is now 28.32.
In the same vein, TMO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 15.95, a figure that is expected to reach 5.95 in the next quarter, and analysts are predicting that it will be 23.68 at the market close of one year from today.
Technical Analysis of Thermo Fisher Scientific Inc. (TMO)
[Thermo Fisher Scientific Inc., TMO] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 22.20% While, its Average True Range was 11.80.
Raw Stochastic average of Thermo Fisher Scientific Inc. (TMO) in the period of the previous 100 days is set at 48.36%, which indicates a major rise in contrast to 23.40% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 15.06% that was lower than 19.79% volatility it exhibited in the past 100-days period.
